Coagulopathy reversal in intracerebral haemorrhage
Alexander J. SweidanNeurology, University of California Irvine Medical Center, Orange, California, USANavneet Kaur SinghMedicine, University of California Irvine Medical Center, Orange, California, USAJoseph ConovaloffNeurology, University of California Irvine Medical Center, Orange, California, USAMatthew M. BowerNeurology, University of California Irvine Medical Center, Orange, California, USALeonid GroysmanNeurology, University of California Irvine Medical Center, Orange, California, USAMohammad ShafieNeurology, University of California Irvine Medical Center, Orange, California, USAWengui YuNeurology, University of California Irvine Medical Center, Orange, California, USA
2020en
ABI
Аннотация
As intracerebral hemorrahge becomes more frequent as a result of an aging population with greater comorbidities, rapid identification and reversal of precipitators becomes increasingly paramount. The aformentioned population will ever more likely be on some form of anticoagulant therapy. Understanding the mechanisms of these agents and means by which to reverse them early on is critical in managing the acute intracerebral hemorrhage.
Ҳали таржима қилинмаган
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба